Allogene Therapeutics Reports Third Quarter 2020 Financial Results

Go back to Allogene Therapeutics Reports Third Quarter 2020 Financial Results
(NASDAQ: ALLO) Delayed: 2.13 -0.1 (4.48%)
Previous Close $2.23    52 Week High
Open $2.19    52 Week Low
Day High $2.21    P/E N/A 
Day Low $2.09    EPS
Volume 1,640,479